Cargando…

High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypes

Autoantibodies (AAbs) targeted tumor‐associated antigens (TAAs) have the potential for early detection of breast cancer. Here, 574 early‐stage breast cancer (ES‐BC) patients containing 4 subtypes (Luminal A, Luminal B, HER2+, TN), 126 benign breast disease (BBD) patients, and 199 normal healthy cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Rongrong, Zheng, Cuiling, Song, Wenya, Tan, Qiaoyun, Shi, Yuankai, Han, Xiaohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819333/ https://www.ncbi.nlm.nih.gov/pubmed/34843149 http://dx.doi.org/10.1111/cas.15227

Ejemplares similares

High-throughput identification of autoantibodies that target the human exoproteome
por: Wang, Eric Y., et al.
Publicado: (2022)

Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta‐analysis
por: Tan, Qiaoyun, et al.
Publicado: (2018)

High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder
por: Mesleh, Areej, et al.
Publicado: (2023)

Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus
por: Zhu, Honglin, et al.
Publicado: (2015)

High-Throughput Sequencing of Human Immunoglobulin Variable Regions with Subtype Identification
por: Schanz, Merle, et al.
Publicado: (2014)

A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
por: Hu, Xingsheng, et al.
Publicado: (2016)

Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients
por: Tan, Qiaoyun, et al.
Publicado: (2020)

Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer
por: Xing, Puyuan, et al.
Publicado: (2018)

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
por: Yan, Yaping, et al.
Publicado: (2016)

MultiGATAE: A Novel Cancer Subtype Identification Method Based on Multi-Omics and Attention Mechanism
por: Zhang, Ge, et al.
Publicado: (2022)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Autoantibodies in early breast cancer: a stage-related phenomenon?
por: Turnbull, A. R., et al.
Publicado: (1978)

Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing
por: Ma, Xiaoshi, et al.
Publicado: (2020)

Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer
por: Chen, Xuesong, et al.
Publicado: (2014)

Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening
por: Mueller, Ralf, et al.
Publicado: (2010)

Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection
por: Macdonald, Isabel K., et al.
Publicado: (2012)

Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations
por: Meroni, Pier Luigi, et al.
Publicado: (2014)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Dynamic Analysis of microRNAs from Different Life Stages of Rhipicephalus microplus (Acari: Ixodidae) by High-Throughput Sequencing
por: Luo, Jin, et al.
Publicado: (2022)

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Clinical relevance of salivary pepsin detection in diagnosing gastroesophageal reflux disease subtypes
por: Zhang, Mengyu, et al.
Publicado: (2023)

Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Lou, Ning, et al.
Publicado: (2023)

Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC
por: Wang, Shasha, et al.
Publicado: (2022)

A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer
por: Hong, Chao-Qun, et al.
Publicado: (2021)

Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis
por: Zhu, Yu-Jin, et al.
Publicado: (2023)

Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda
por: Kibirige, Davis, et al.
Publicado: (2022)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease
por: Poulakis, Konstantinos, et al.
Publicado: (2022)

The role of autoantibody detection in the diagnosis and staging of lung cancer
por: Wang, Yun, et al.
Publicado: (2021)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

First-emerging islet autoantibody and glucose metabolism: search for type 1 diabetes subtypes
por: Helminen, Olli, et al.
Publicado: (2022)

Genetic alteration profiling of patients with resected squamous cell lung carcinomas
por: Tao, Dan, et al.
Publicado: (2016)

Combined detection of serum Dickkopf‐1 and its autoantibodies to diagnose esophageal squamous cell carcinoma
por: Peng, Yu‐Hui, et al.
Publicado: (2016)

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
por: Terkelsen, Thilde, et al.
Publicado: (2021)

A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications
por: Patel, Akshay J., et al.
Publicado: (2021)

Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
por: Shen, Lei, et al.
Publicado: (2017)

Serum Autoantibodies: From Identification to Clinical Relevance
por: Invernizzi, Pietro, et al.
Publicado: (2013)

Identification of Novel Autoantibodies for Detection of Malignant Mesothelioma
por: Zhang, Xufei, et al.
Publicado: (2013)

Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma
por: Welberry, Christopher, et al.
Publicado: (2020)

Multi‐ATOM: Ultrahigh‐throughput single‐cell quantitative phase imaging with subcellular resolution
por: Lee, Kelvin C. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kpkgda1j5r7rpcrc7sum5plsag